bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
Quick Stats
Feb 02, 202638.7
AI Score
SELL6.24
Volume Ratio
Next Earnings
12
+ve Days (30d)
14
-ve Days (30d)
BIAF Stock Summary
Last updated Feb 02, 2026
BIAF is currently trading at $1.27, positioned below its 200-day moving average of $2.43, suggesting bearish momentum. The stock has a 52-week range of $0.134 to $46.53.
Technical Analysis: The 50-day moving average stands at $1.36, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 46.307, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.089, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BIAF at 38.7/100 with a SELL recommendation.
BIAF (bioAffinity Technologies, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 46.307 |
| CMF (20) | -0.089 |
| ROC (10) | -7.299 |
| ADX (14) | 14.686 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.049 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -42.579 |
| MFI (14) | 63.62 |
BIAF Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
BIAF Price vs Max Options Open Interest
BIAF Max Change In Options Open Interest
BIAF Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BIAF Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BIAF Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
BIAF Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
bioAffinity Technologies, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
BIAF Moving Averages Analysis
BIAF (bioAffinity Technologies, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 1.26 |
| 20 | 1.28 |
| 30 | 1.26 |
| 50 | 1.36 |
| 100 | 1.9 |
| 200 | 2.43 |
BIAF Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 5.1 million |
| Earnings/Share ($) | -13.83 |
| Net Proft Margin (%) | -2.175 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -14.4 |
| EPS Estimate Next Year ($) | -8.1 |
| WallStreet Target Price ($) | 6 |
| Most Recent Quarter |
News: $IINN experiences after-hours volume alert, signaling potential sector breakout similar to $BIAF. $BIAF sees a significant increase of 214% with real private placement catalyst. Investors anticipate a reversal in the next few hours.
Updated 2025-09-26 17:00:03